1. Home
  2. ECOR vs CNVS Comparison

ECOR vs CNVS Comparison

Compare ECOR & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • CNVS
  • Stock Information
  • Founded
  • ECOR 2005
  • CNVS 2000
  • Country
  • ECOR United States
  • CNVS United States
  • Employees
  • ECOR N/A
  • CNVS N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CNVS Consumer Electronics/Video Chains
  • Sector
  • ECOR Health Care
  • CNVS Consumer Discretionary
  • Exchange
  • ECOR Nasdaq
  • CNVS Nasdaq
  • Market Cap
  • ECOR 57.5M
  • CNVS 56.6M
  • IPO Year
  • ECOR 2018
  • CNVS 2003
  • Fundamental
  • Price
  • ECOR $6.19
  • CNVS $3.15
  • Analyst Decision
  • ECOR Strong Buy
  • CNVS Buy
  • Analyst Count
  • ECOR 2
  • CNVS 1
  • Target Price
  • ECOR $25.50
  • CNVS $10.00
  • AVG Volume (30 Days)
  • ECOR 213.2K
  • CNVS 75.0K
  • Earning Date
  • ECOR 03-12-2025
  • CNVS 02-13-2025
  • Dividend Yield
  • ECOR N/A
  • CNVS N/A
  • EPS Growth
  • ECOR N/A
  • CNVS N/A
  • EPS
  • ECOR N/A
  • CNVS N/A
  • Revenue
  • ECOR $25,182,000.00
  • CNVS $72,469,000.00
  • Revenue This Year
  • ECOR $40.88
  • CNVS $59.61
  • Revenue Next Year
  • ECOR $48.01
  • CNVS N/A
  • P/E Ratio
  • ECOR N/A
  • CNVS N/A
  • Revenue Growth
  • ECOR 57.09
  • CNVS 39.86
  • 52 Week Low
  • ECOR $5.32
  • CNVS $0.72
  • 52 Week High
  • ECOR $19.49
  • CNVS $4.89
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 17.57
  • CNVS 35.44
  • Support Level
  • ECOR $6.57
  • CNVS $3.03
  • Resistance Level
  • ECOR $7.05
  • CNVS $3.65
  • Average True Range (ATR)
  • ECOR 0.87
  • CNVS 0.19
  • MACD
  • ECOR -0.11
  • CNVS -0.03
  • Stochastic Oscillator
  • ECOR 2.64
  • CNVS 15.79

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Share on Social Networks: